Clinical Trial Billing Compliance at UAB
|
|
- Matilda Hicks
- 6 years ago
- Views:
Transcription
1 Clinical Trial Billing Compliance at UAB Carolyn P. Whitmire, MBA, CHRC Director, Research Implementa?on Co- Administra?ve Director, Clinical Trials Office
2 UAB Infrastructure Campus and Health System are separate en??es Separate Health System billing offices and systems Hospital Healthquest Health Services Founda?on (HSF) - IDX Electronic medical record (EMR) - Cerner Clinical trial ac?va?on process occurs on campus side Campus, Health System and School of Medicine partner to fund a Clinical Trials Office concept Coordinated effort between VP for Research, School of Medicine and Health System to improve the clinical trial ac?va?on process and posi?on UAB to grow its clinical trial business
3 UAB and Clinical Trials Over 3,000 ac?ve IRB protocols 800 1,000 ac?ve clinical trials u?lize clinical services provided and billed by UAB Health System
4 History of UAB and Clinical Trial Billing Compliance Created Research Compliance Office in response to OIG subpoena for informa?on about clinical trials billing and effort repor?ng Created a paper- based clinical trial billing no?fica?on (CTBN) process to inform the Health System billing offices Implemented a robust clinical trial billing audi?ng plan and required training for effort repor?ng Implemented Coverage Analysis Process in 2005/2006 Harmoniza?on of billing grid, contract, budget and informed consent Implemented SiteMinder Clinical Trial Management System (CTMS) to automate the paper CTBN process Focused only on those research projects with services provided and billed by UAB Health System Research Compliance Office renamed University Compliance Office and scope of responsibili?es expanded in 2010
5 Clinical Protocol Ac;va;on Process UAB Clinical Protocol Ac?va?on Process Coverage Analysis should occur early in the ac?va?on process, preferably prior to: Submission to Office of Sponsored Programs Submission to Office of the Ins?tu?onal Review Board Ini?a?on of budget nego?a?ons Approved billing matrix is built into a CTMS to drive our billing compliance no?fica?ons
6 Current CTMS Process Overview
7 No;fica;ons from CTMS to Billing Offices Data Feed #1. SM budget must be finalized no less than 24 hours prior to the first subject enrolled date. The data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO creates occ/med dictionary entry for the study, and Hospital Lab initiates steps to create institutional lab account, if applicable. Hospital PFS takes no action in HQ at this point. Data Feed #2. Patient record created in SM and patient linked to study on the day consent is signed. The data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO creates a case for the patient in IDX. Hospital Lab/Hospital PFS does not take action on this data feed.. Data Feed #3. Research appointments should be added to the SM calendar no later than 5pm the day before the visit date. NOTE: There is an exception report here which includes visits scheduled in SM after the visit date. This data feed is generated daily at 11pm and sent to Hospital and HSF to be worked the next business day. MSO and Hospital PFS use this information to compare to accounts in HQ and appointments in IDX and where there is a match, the appointment/account is flagged to be billed after receipt of a CTBN. Data Feed #4. For visits where the appointment is in the SM calendar by 5pm the day before the visit date, the visit can be kept no later than 48 hours (excluding weekends) after the visit date. CTBN s are generated every 2 hours for SiteMInder visits that have been kept. This data is available to the Health System billing offices via an on- line database. For a visit where the criteria described for data feed #3 is not met, the visit must be kept on the day of the visit.
8 Clinical Trial Billing No;ce
9 Problems with Current Process Limited informa?on to assess the performance of our clinical trial book of business Unclear policies and expecta?ons for clinical trial budget development and financial management Financial losses due to under- es?ma?on of costs or over- es?ma?on of enrollment Duplica?on of effort by study teams leads to tardy CTBNs to billing offices Inefficient or unavailable tools for financial management of clinical trials Inefficient and manual processes
10 Changes on the Horizon Require a coverage analysis for all clinical trials Require an internal cost analysis (i.e. budget) for all clinical trials Must be approved by department or division Require the use of a CTMS to manage all aspects of a clinical trial Implement Cerner s PowerTrials product to support ordering of clinical services for research {this process facilitates billing compliance}
11 Future State with CTMS and PowerTrials (EMR)
12 Clinical Trial Budget and Billing Plan Downloadable version to excel to reflect costs versus charge by ac?vity and by visit
13 Research PowerPlan Segregates Research Only versus Rou;ne Care Research SOC Billing Charges appear on ins?tu?onal account; automa?cally discounted to the correct research rate Charges appear on pa?ent account with appropriate billing modifiers
14 PowerTrials Implementa;on Approach Begin with most frequently u?lized clinical services clinical lab and radiology Inpa?ent clinical trials to be addressed in subsequent phase Design process for protocol amendments and their impact on the clinical trial budget and research powerplan A CTBN (detailed account of visit ac?vity per pa?ent) will con?nue to exist in CTMS but use of this informa?on will transi?on to more of a monitoring/compliance tool versus a tool used in day- to- day billing ac?vi?es
15 Challenges Blinded studies Clinical services that should not be part of pa?ent s medical record Coordinated approach to pa?ent care clinical care and research care
16 Key Lessons Learned Execu?ve and School leadership and support is essen?al Require the use of a clinical trial management system (CTMS) to facilitate the overall management of a clinical trial Integrate CTMS with other systems to the extent possible Include study team members in the design of future state Develop clear policies and expecta?ons along with clearly defined roles/responsibili?es Design processes with input from subject maker experts and include built- in compliance checks Implement a robust monitoring plan for billing compliance
17 Ques;ons????? Contact informa;on: Tracy Popp Norton Healthcare Carolyn Whitmire The University of Alabama at Birmingham
Help Your Account Holders Instantly Fund & Switch Their Primary Account to Your Financial Ins<tu<on
Presentation and video replay will be provided within one week. Have questions? Use the questions panel - we ll field them as we go and during the Q&A recap Help Your Account Holders Instantly Fund & Switch
More informationAssessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites
SAMPLE CUSTOM MARKET RESEARCH REPORT Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites An Analysis of Company- Specific Results From the CenterWatch 2013 Survey of Global InvesBgaBve
More informationAssessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites
SAMPLE CUSTOM MARKET RESEARCH REPORT Assessing the Quality {Company s} Rela7onship with its Inves7ga7ve Sites An Analysis of Company- Specific Results From the CenterWatch 2013 Survey of Global InvesBgaBve
More informationNational Research Network 2012 Benchmark Report
National Research Network 212 Benchmark Report The National Research Network 212 Benchmark Report pulls together real world performance data from hospitals, universities and government agencies across
More informationNational Research Network 2011 Benchmark Report
National Research Network 211 Benchmark Report The National Research Network 211 Benchmark Report pulls together real world performance data from hospitals, universities and government agencies across
More informationIBM Clinical Trial Management System for Sites
Service Description IBM Clinical Trial Management System for Sites This Service Description describes the Cloud Service IBM provides to Client. Client means the contracting party and its authorized users
More informationResearch and the EHR: Process Improvement Through Integration
Research and the EHR: Process Improvement Through Integration Session 160, March 8, 2018 Arash Naeim, MD PhD, Chief Medical Research Officer, UCLA Health System Marti Arvin, VP of Audit Strategy, CynergisTek
More informationIBM Clinical Trial Management System for Sites
Service Description IBM Clinical Trial Management System for Sites This Service Description describes the Cloud Service IBM provides to Client. Client means the contracting party and its authorized users
More informationClinical Trials Office VPR CTO
Clinical Trials Office VPR CTO Velos eresearch Mysti M. Trainer Budget Analyst - Associate Who is the VPR-CTO? Serve Under the Vice President for Research Part of the Research Administration We work closely
More informationThe Beryl Ins,tute Pa,ent Experience Webinar Series
www.theberylins,tute.org The Beryl Ins,tute Pa,ent Experience Webinar Series Defining Pa,ent Experience The sum of all interactions, shaped by an organization s culture, that influence patient perceptions
More informationSponsor/Investigator Responsibilities
Sponsor/Investigator Responsibilities Marian Serge, RN Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health Food and Drug Administration Marian.Serge@fda.hhs.gov
More informationA Management Systems Approach to Ergonomics Programs. Elise Condie, M.S., CPE Senior Consultant
A Management Systems Approach to Ergonomics Programs Elise Condie, M.S., CPE Senior Consultant What is OHSAS 18001? An interna)onal standard for occupa)onal health and safety management systems (OHSMS)
More informationSuccessful Changes with Integrated Change and Project Management
Successful Changes with Integrated Change and Project Management Markus F. Wanner, Managing Partner, Representative of Management, Tiba Management Consulting, Munich/ Germany 1 A way to success?? 2 Agenda
More informationModule One: Produc.ve Management Methodology for Health Services (PMMHS) An Introduc.on Part 2
Module One: Produc.ve Management Methodology for Health Services (PMMHS) An Introduc.on Part 2 What is PMMHS? It is a methodology for the management of health services based on produc.on, efficiency, resources
More informationTop 5 Ways to Improve Your Billing & Collec=ons
Top 5 Ways to Improve Your Billing & Collec=ons Presenters: Jillian Longpre Vice President Franco Rizzolo, DC CEO Brought to you by: Industry leading Educa1on Cer1fied Partner Program Please ask ques1ons
More informationOnCore Billing Compliance Workflow Demonstration
Srini Kalluri, Founder, President & Chief Customer Officer Carrie Nemke, Business Development Manager CTMS Support of Billing Compliance Best Practices Research Compliance Conference Austin TX, June 2013
More informationPla$orm for Engaging Everyone Responsibly (PEER)
Pla$orm for Engaging Everyone Responsibly (PEER) We begin with a novel perspec
More informationShare-based Payment IFRS REPORTING
YOUR PARTNER IN PARTICIPATION SOLUTIONS Innova3ve So4ware You Can Trust Share-based Payment IFRS REPORTING Introduc3on In many organizes ICT, Finance, Human Resources and Legal are separate departments
More informationTransla(ng Principles to Performance Crea(ng a Global System to Promote Responsible Conduct of Human Research by Physicians
Enhancing Safety, Quality and Efficiency in Medicines Development and Health Research through Systems Solu>ons Transla(ng Principles to Performance Crea(ng a Global System to Promote Responsible Conduct
More informationWORKLOAD PLANNING, WORK EFFORT MANAGEMENT & WORK FLOW DIAGRAMS
WORKLOAD PLANNING, WORK EFFORT MANAGEMENT & WORK FLOW DIAGRAMS TIPS AND TECHNIQUES FOR MANAGING YOUR SITE RESOURCES Hosted by Dial-In Information: Webinar ID: 831655168 Audio: (888) 824-5783 Access Code:
More informationProtec'ng Privacy in the Archives: Preliminary Explora'ons of Topic Modeling for Born- Digital Collec'ons
Protec'ng Privacy in the Archives: Preliminary Explora'ons of Topic Modeling for Born- Digital Collec'ons Tim Hutchinson 13 December 2017 IEEE 2017: 2 nd CAS Workshop Guiding ques'ons/context! High volume
More informationWHAT IS OUR RESEARCH PORTFOLIO?
Clinical Research Management System Online Collaborative Research Environment (OnCore) Forte Research Systems Christian Stephens Office of Research Informatics Project Manager Mike Neuenfeldt Forte Project
More informationIXRS DATA TO INFORMED DECISION MAKING. Linda Chan-Kim October 2015
IXRS DATA TO INFORMED DECISION MAKING Linda Chan-Kim October 2015 Table of Contents Genentech Overview EMMA Data Issues What did we do? 2 2 Roche Group An innovation network 3 South San Francisco is home
More informationCompassionate Use Navigator Information for Physicians
Compassionate Use Navigator Information for Physicians Contact: Elena Gerasimov, Program Director, Elena@kidsvcancer.org. As a physician, you must have wished there would be more treatment options for
More informationUnique Device Identifiers (UDIs) The Next Big Step for Effective Analysis. Bill A. Bobbie President, Cook (Canada) Inc.
Unique Device Identifiers (UDIs) The Next Big Step for Effective Analysis Bill A. Bobbie President, Cook (Canada) Inc. May 16, 2017 Agenda UDI Background A Manufacturer s Journey Implemen;ng UDI Labels
More informationHub Performance Assessment
Hub Performance Assessment Hub complex performance assessment will be assessed with a standardized report card mechanism. The report card draws on data quality reports, enrollment reports, and monitoring
More informationClinical Trials Series Part II
Clinical Trials Series Part II Agenda Recap December Presentation J. Schmelz Example: New CT from HSC Investigator Non Cancer Clinical Trial J. Bates, P. Miranda Example: New CT from External Entity Non
More informationROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016
UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016 Objectives Define the sponsor of a clinical trial and learn
More informationCompliance and Quality Monitoring: What, Why, When, and How
Compliance and Quality Monitoring: What, Why, When, and How Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Research Institute, University
More informationResearch 101. Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015
Research 101 Health Care Compliance Association Regional Conference Columbus, Ohio May 8, 2015 Jennifer Lanter, MSPH, BSN, RN, CCRC Director, Research & Special Billing Office Agenda Research Compliance
More informationAudit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.
Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,
More informationSOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018
SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018 CLINICAL TRIALS FINANCIAL MANAGEMENT ADMINISTRATIVE CHALLENGES & CONSIDERATIONS Agenda 1. Introduction 2. Challenges in Clinical Trial Financial
More informationWorkforce Management KPIs That Ma)er
Businesses Run Be)er on Kronos Workforce Ready Workforce Management KPIs That Ma)er Sponsored by 1 Kronos Workforce Ready Delivers Key Performance Indicator (KPI) Improvements to Customers Helping organisahons
More informationLaboratory Information system is. Laboratory Information System
Laboratory Information System The Laboratory Information system module is used by the pathology lab to record and disseminate the information regarding the tests performed. The Laboratory department receives
More informationProject Management. Project Planning CE PROJECT MANAGEMENT L- 5
Project Management Project Planning CE 447 - PROJECT MANAGEMENT 1 L- 5 Project Phases 1. Ini7a7on 2. Planning 3. Execu7on 4. Controlling 5. Closing Planning Phase Communica7on plan Scope management plan
More informationIT System Scope Development. Presented by Lourdes Coss, MPA, CPPO
IT System Scope Development Presented by Lourdes Coss, MPA, CPPO Objec4ves Discuss Key Components of an IT System Scope of Services Prac?ce the Development of the Document Discuss some of the laws of teamwork
More informationAmerican Samoa Community College
American Samoa Community College Fall 2015 Convoca8on Accredita8on Status August 10, 2015 Our purpose is our Mission The mission of the American Samoa Community College is to foster successful student
More informationAASBO May /1/17. Posi*on Control as a Management Tool. Posi2on Control Basics Master Posi2on
AASBO May 2017 Posi*on Control as a Management Tool Objec2ves of Posi2on Control Ensure that all Employees are Assigned to Authorized and Funded Posi*ons Streamline Workflow Between HR and PR Eliminate
More informationFREQUENTLY ASKED QUESTIONS
CLINICAL TRIALS FREQUENTLY ASKED QUESTIONS PARTICIPATING IN A CLINICAL TRIAL What is a clinical trial? Clinical trials are research studies that involve people. Through clinical trials, researchers find
More informationUsing NIHR validated workforce tools to determine capability & capacity at UHB
Using NIHR validated workforce tools to determine capability & capacity at UHB Joanna Gray Fiona McGlynn Sarah Dhariwal Joanne Plumb Aims To identify and share workforce planning solutions at University
More informationSOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS
SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning
More informationSt. Luke s University Health Network
Page 1 of 5 PURPOSE: This standard operating procedure (SOP) applies to the activities involved in the collection and handling of laboratory specimens from patients enrolled in clinical studies subject
More informationDiabetes Obesity Control Program
Diabetes Obesity Control Program Pre-Read for External Review Prepared by Lynda Chin June 2016 For the Blue Ribbon Panel Use Only Confiden8al Do Not Distribute 1 Chronic Disease Burden Worldwide: $47 trillion
More informationBeyond Hydraulic Fracturing Chemicals: Beneficial Reuse of Oil Field Produced Water for Irriga>on of Agriculture
Beyond Hydraulic Fracturing Chemicals: Beneficial Reuse of Oil Field Produced Water for Irriga>on of Agriculture Seth B.C. Shonkoff, PhD, MPH 1,2,3 1 PSE Healthy Energy, Inc. 2 University of California,
More informationStudy Files and Filing
Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm
More informationMVP Access Program Access to Data and Sera collected during the MenAfriVac clinical trials
MVP Access Program Access to Data and Sera collected during the MenAfriVac clinical trials 23 February 2016 The MVP Closure Conference Lionel Martellet Clinical Opera0ons Manager Presenta;on Overview 1.
More informationEHR 2.0 Collaboration
2.0 Collaboration Electronic Health Records User Experience October 5, 2010 Tina Buop CIO, Muir Medical Group IPA,., Inc Debra Spindel VP, Nautilus Healthcare Management Group, LLC Agenda Introduction
More informationCase Study: University of Washington s Clinical Research Billing Audit Program
Case Study: University of Washington s Clinical Research Billing Audit Program 7 th Annual Conference for Effective Compliance Systems in Higher Education Richard A. Meeks, CCEP Agenda Background Probe
More informationSWOG
SWOG http://swog.org Page 1 of 5 pages Original Release Date: July 1985 Departments Affected: All Revision Date: April 2018 Introduction SERIOUS ADVERSE EVENTS The timely reporting of serious adverse events
More informationAR-CRIS Comprehensive Research Informatics Suite ANGIE SMITH, MS, CCRP, PMP DIRECTOR OF IT RESEARCH SYSTEMS UAMS IT RESEARCH
AR-CRIS Comprehensive Research Informatics Suite ANGIE SMITH, MS, CCRP, PMP DIRECTOR OF IT RESEARCH SYSTEMS UAMS IT RESEARCH Overview of AR-CRIS Arkansas Comprehensive Research Informatics Suite (AR-CRIS)
More informationKentucky PCA Annual Mee0ng October, Coleman Associates. The Hub of the PCMH Coleman Associates. Let me in!
Improving Patient Access By Revamping Your Schedule and Managing Your Pa0ent Popula0on 1 The Hub of the PCMH 2 Let me in Give me the best What Pa6ents Want Don t waste my 6me Figure me out & fix me Care
More informationMAP KEYS OVERVIEW and CASE STUDY Thursday, March 10, to 3:30 pm
Association of Illinois Access Management Patient Access No Bed of Roses Rosewood Restaurant, Rosemont, IL MAP KEYS OVERVIEW and CASE STUDY Thursday, March 10, 2011-2 to 3:30 pm Suzanne K. Lestina, FHFMA,
More informationPresenters Details: Saul Jankelow Title of Presenta5on: So6ware as a medical device Date: 24 August 2017
Presenters Details: Saul Jankelow Title of Presenta5on: So6ware as a medical device Date: 24 August 2017 So#ware as a medical device (SaMD) So6ware has become cri5cally important in the efficient running
More informationExternal IRB Review What Does it Mean for Your Institution
External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA
More information10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.
Wednesday October 10, 2012 Please be sure to sign in and take copies of each handout. 1 Alicia Joy, IRB 2 FH Office of Research Administration Christina Jackson, BSN, RN, CCRC, CHRC 1 ClinicalTrials.gov
More informationUsing Technology to Reduce Costs and Improve Quality
Using Technology to Reduce Costs and Improve Quality Kari Cornicelli, FHFMA, CPA VP, CFO Sharp Grossmont Hospital SOHL, HIMSS, and HFMA Joint Chapter Meeting 9/20/12 HFMA s Value Project Objectives Understand
More informationSERIOUS ADVERSE EVENTS
EVENTS Introduction Timely reporting of Serious Adverse Events (SAEs) is required by regulations of the Food and Drug Administration (FDA) and the National Cancer Institute (NCI). Such reporting is not
More informationDetails: Approval: Distribution & Storage:
Details: Author: Neville Young Quality Assurance Manager SOP Pages: Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person approving
More informationClinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014
Clinical Trials and the Code of Federal Regulations Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014 The Development of Regulations 1906: Food and Drugs Act
More informationDisrup'ng the Status Quo of Reac've Pricing
Disrup'ng the Status Quo of Reac've Pricing Jeremy Pifer Director of Pricing Hologic: The Science of Sure Innova've healthcare company with market- leading products for early detec'on and interven'on,
More informationEmpowering Students Through Peer Mentorship. NAFSA Northern District Conference March 13, 2017
Empowering Students Through Peer Mentorship NAFSA Northern District Conference March 13, 2017 Keri Toma Interna;onal Programs Coordinator UC Santa Cruz Today s Plan 1. UC Santa Cruz Interna;onal Mentorship
More informationClinical Trials Billing Audit Internal Audit Report 18:02
Office of Internal Audit Clinical Trials Billing Audit Internal Audit Report 18:02 October 12, 2018 Table of Contents I. Executive Summary 3 Background 3 Scope and Objectives 5 Conclusion 6 II. Detailed
More informationEPIC UPGRADE NOVEMBER 2017 RESEARCHER NOTES FOR STUDY-RELATED IMAGING
EPIC UPGRADE NOVEMBER 2017 RESEARCHER NOTES FOR STUDY-RELATED IMAGING Use of the current paper Radiology Research Order forms will be discontinued in conjunction with EPIC go-live. After EPIC go-live,
More informationThe RIGHT care, at the RIGHT time, for the RIGHT outcome.
The RIGHT care, at the RIGHT time, for the RIGHT outcome. The New WSIB Surviving the Changes? Unlocking the Secret to WSIB Management Liz R. Scott, PhD Principal Organizational Solutions Inc. AGENDA Introduc/on
More informationESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL
Assemble Essential Documents in Trial Master File (TMF) Appendix 1 ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 8.2 Before the Clinical Phase of the Trial Commences During this planning stage
More informationEuroNet- PHL- C2 trial set- up and trial monitoring
EuroNet- PHL- C2 trial set- up and trial monitoring Chris9ne Mauz- Körholz Department of Pediatrics Pediatric Hematology and Oncology UKGM, Justus- Liebig University of Gießen, Germany ScienCfic Secretary
More informationResurrection Health Care Transforming Document Processing with Intelligent Data Capture
Resurrection Health Care Transforming Document Processing with Intelligent Data Capture Today s Guest Speaker Robert Banwart Director of Accounts Payable Resurrec'on Health Care Company Experience: Sun
More informationYour Hospital. Food & Nutrition Service Excellence Boot Camp. Featuring Chris Thrash. Prepared for: Prepared by:
Food & Nutrition Service Excellence Boot Camp Featuring Chris Thrash Prepared for: Prepared by: Innovative ity Solutions, Inc. 35473 Red Tail Road Lewes, DE 19958 302-231-2333 Project Overview Crea)ng
More informationGLOBAL Trend and opportunities in drug development
GLOBAL Trend and opportunities in drug development พญ อรณ ต งเผ า Oranee T Daniels MD October 2015 Looking back during last 15 years Drug safety became a focus for both regulators and drug developers.
More informationPresident. Duties & Responsibilities. Skill Requirements Leadership, coaching, mentoring, and motivation
IABC Chapter Leader Job Description Template IABC has developed these suggested board roles for chapters to adopt. Chapters may use these descriptions as a template and can customize each role to meet
More information4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.
POLICY #: RCO-203 Page: 1 of 7 1. POLICY STATEMENT: Essential regulatory documents will be on maintained for research sponsored by or conducted at Dana-Farber/Harvard Cancer Center (DF/HCC) to assure compliance
More informationMMC-Einstein Research IT Forum
MMC-Einstein Research IT Forum June 7, 2017 Harry Shamoon, Associate Dean for Clinical & Translational Research Barrett Katz, Executive Director, Office of Clinical Trials Vic Hatcher, Associate Dean for
More informationRichard Close Pfizer, Inc. Groton, CT Professional Experience
Richard Close Pfizer, Inc. Groton, CT 860-501-3117 Richard.close@pfizer.com Richard Close Professional Experience Executive Director, Pfizer, Inc. Development Operations, Clinical Informatics and Innovation
More informationDRUG ORDERING AND MAINTENANCE
AND MAINTENANCE Disclaimer: Please note that the instructions provided in this chapter mainly apply to agents provided by the Pharmaceutical Management Branch (PMB), of Cancer Therapy Evaluation Program
More informationResearch Governance Policy and Procedure
Research Governance Policy and Procedure Version: 5 Name of originator/author: Name of executive lead: Date ratified: Review date: APPLICABLE TO: All staff. EXECUTIVE SUMMARY Dr Lisa Austin- University
More informationSponsor-Investigator Responsibilities In Clinical Trials
In Clinical Trials Margaret Huber, RN, BSN, CHRC Compliance Manager The lecturer has no conflicts for this presentation 9/23/2015 Objectives Define terms sponsor, investigator, and sponsor-investigator.
More informationLong Term 2 Enhanced Surface Water Treatment Rule & Ground Water Rule Updates for Oklahoma Water Systems
Long Term 2 Enhanced Surface Water Treatment Rule & Ground Water Rule Updates for Oklahoma Water Systems June 2014 October 1, 2013 Administra5on of three Drinking Water Rules transferred from EPA to Oklahoma
More informationFinal Outcome of ASW Symposium
Symposium on the ASEAN Single Window and National Single Windows Borobudur Hotel, Jakarta, Indonesia 18 September 2012 Summary of Session 5 Final Outcome of ASW Symposium 1 ü The current ASW architecture
More informationUCLA UCPath Update. Common Systems Group. July 28, UCPath at UCLA. Confiden'al. For internal UCLA use only.
UCLA UCPath Update Common Systems Group July 28, 2015 Confiden'al. For internal UCLA use only. Agenda Scope of UCPath Project governance How we got here Scope of work for UCLA Campus systems effort: Data
More informationNew gtld Program Update! 08 April 2013! Chris&ne Wille, ICANN, VP gtld Opera&ons
New gtld Program Update! 08 April 2013! Chris&ne Wille, ICANN, VP gtld Opera&ons Agenda! + Accomplishments since Toronto meeting + Timeline + Application Processing - Initial Evaluation Status - Objections
More informationSYSTOC Designed specifically for occupational medicine clinics and practices
SYSTOC Designed specifically for occupational medicine clinics and practices Real-Time Healthcare Requires Real-Time Records Your customers require the highest quality occupational healthcare for their
More informationClinical Trial Transparency UK perspective
Clinical Trial Transparency UK perspective Dr Bina Rawal Medical, Innovation & Research Director Association of the British Pharmaceutical Industry January 2014 1 Outline Transparency timeline Campaign
More informationExpanded Access and the Individual Patient IND
Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office
More informationSponsorship of Clinical Research Studies
Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use
More informationMelanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst
NEW CLINICAL RESEARCH BILLING SCHEDULE Melanie Hawkins, BSN, RN, CCRC Director, Clinical Research Billing Compliance Kristin Pattee Couture, CCRP Clinical Research Coverage Analyst What is a billing schedule
More informationDemystifying Audits. Audits and Audit Preparation 5/23/2016. What is an Audit?
Demystifying Audits Darlene Kitterman, MBA Director, Investigator Support & Integration Services OCTRI May 26, 2016 Audits and Audit Preparation What is an Audit? A systematic and independent examination
More informationJune 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB
June 15, 2016 Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA five consecutive audits
More informationNEUROENDOVASCULAR TRIALS
1 NEUROENDOVASCULAR TRIALS Understanding your Research Role in Stroke and Device Trials Tuesday, June 09, 2015 2 Biography Christy Anton is a Clinical Research Coordinator at Rush University Medical Center.
More informationBuilding Cultural Competence through Sustainable Change: Findings from the NCHL Diversity Leadership Demonstra?on Project
Building Cultural Competence through Sustainable Change: Findings from the NCHL Diversity Leadership Demonstra?on Project Judith G. Bryant, MSOD NCHL Diversity Leadership Organizational Coach Judithbryant@consultant.com
More informationA Panoramic View of Campus Shared Services
A Panoramic View of Campus Shared Services Peggy Huston, Chief Opera,ng Officer, Campus Shared Services Cathy Jen, Service Director, Campus Shared Services Team 2/ERSO Sandi Ketchpel, Assistant Dean of
More informationThe Research Services Organization (RSO) of the Academic Health Center
Annual Report 2005 The Research Services Organization (RSO) of the Academic Health Center A Summary of the Eighth Year of Operations Submitted by: Mark S. Paller, M.D., M.S. Director, Research Services
More informationOptimizing your Billing Process
Optimizing your Billing Process Samantha Charles Greenfield Health GreenField Health Fee based practice founded in 2001 Seven physicians in two locations Four integrated business units Redesigned medical
More informationOptimizing Triple Aim Performance via Incentives, Transparency, and Best Practice Implementation
Optimizing Triple Aim Performance via Incentives, Transparency, and Best Practice Implementation Mary Barton Durfee, MD Executive Vice President & Chief Medical Officer Richard Duffy, MBA Vice President
More informationDRUG ORDERING AND MAINTENANCE
AND MAINTENANCE Disclaimer: Please note that the instructions provided in this chapter only apply to agents provided by the Pharmaceutical Management Branch (PMB), of Cancer Therapy Evaluation Program
More informationWork Instruction - Research Billing Risk
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO Work Instruction - Research Billing Risk Velos eresearch Version 9.2 Version: 2.0, 04/03/2015 Revision History Version/Amendment #: Version
More informationI. Purpose. II. Definitions. Last Approval Date
Investigational Drugs and Biologics Page 1 of 13 I. Purpose The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics
More informationDEVELOPING CLINICAL TRIALS INFRASTRUCTURE
DEVELOPING CLINICAL TRIALS INFRASTRUCTURE SESSION IV of IOM Workshop: Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020 PAUL EISENBERG PETRA KAUFMANN
More informationIndex of Standard Operating Procedures for all research Sponsored by the UHL
University Hospitals of Leicester NHS Trust () Index of Standard Operating Procedures for all research Sponsored by the March Please note that with effect from 2015, all SOPs and Appendices use the same
More informationUT SOUTHWESTERN MEDICAL CENTER AT DALLAS INSTITUTIONAL REVIEW BOARD. Emergency Use of an Investigational Drug, Biologic or Device
Emergency Use of an Investigational Drug, Biologic or Device Introduction The emergency use provision in the FDA regulations (21 CFR 56.102d) is an exemption from prior review and approval by the IRB for
More informationClinical Research Billing Systems
Clinical Research Billing Systems Internal Audit Report No. I2017-202 January 30, 2017 Prepared By Mike Shead, Senior Auditor Reviewed By Niran Joshi, Associate Director Approved By Mike Bathke, Director
More information